BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals has informed the exchange that its trading window is closed in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. This means directors, employees, and other designated insiders are barred from buying or selling the company's shares for a specified period. Such closures typically take place ahead of a board meeting, financial results announcement, or other material corporate event. No specific dates or financial details have been disclosed in this filing.
This is a routine regulatory filing with no direct impact on the stock price. However, it may hint that a material announcement — such as quarterly results or a corporate action — is forthcoming once the window reopens.